suministro del medicamento exclusivo PEPAXTI, comercializado por ONCOPEPTIDES AB, para los centros hospitalarios dependientes del Servicio de Salud de las Islas Baleares.
TED · 631675-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Servicio de Salud de las Illes Balears in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| VANTIVE HEALTH, S.L. | 2 | €814,500 | 2026-05-05 |
| ALNYLAM PHARMACEUTICALS SPAIN, S.L. | 1 | €4,596,376 | 2026-05-08 |
| ASTELLAS PHARMA, S.A. | 1 | €3,539,037 | 2026-07-10 |
| BIOMERIEUX ESPAÑA, S.A. | 1 | €1,480,000 | 2026-05-11 |
| FRESENIUS MEDICAL CARE ESPAÑA, S.A.U. | 1 | €466,350 | 2026-04-30 |
Full buyer profile: what Servicio de Salud de las Illes Balears buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
suministro del medicamento exclusivo PEPAXTI, comercializado por ONCOPEPTIDES AB, para los centros hospitalarios dependientes del Servicio de Salud de las Islas Baleares.